Curs Urgente An 6 - Aritmii AD Aprilie 2023
Curs Urgente An 6 - Aritmii AD Aprilie 2023
Curs Urgente An 6 - Aritmii AD Aprilie 2023
ARRHYTHMIAS
Alexandru Deaconu
Senior Lecturer UMF Carol Davila
Cardiologist
LIFE-THREATENING
ARRHYTHMIAS
• Bradyarrhythmias:
• Infra-nodal AV block
• Tachyarrhythmias:
• Malignant ventricular arrhythmias
SIGNIFICANCE – CLINICAL ASPECTS
• Symptoms:
• Due to cardiac output
• cerebral: dizziness-fainting syncope ( Adams-Stokes Sd.)
• cardiac: angina
• renal: Kussmaul breathing coma
• muscular: fatigue
• Due to congestion
• pulmonary
• peripheral
• Signs
• Of cardiac output
• Of congestion
Where is the P?
ILR
QUESTION:
WHAT IS THE DIAGNOSIS?
A.SSS
B.AVB
C.Both
D.Don’t know…
(only one answer please)
SAN DYSFUNCTION
• Sinus bradycardia
• Sinus arrests
A.SSS
B.AVB
C.RBBB
D.Don’t know…
(multiple answers possible)
CONDUCTION SYSTEM
DISTURBANCES
• AV blockNodal
Or
• First degree
• Second degree: Mobitz 1/Mobitz 2
Infranodal
• Third degree (complete)
• ECG:
• No relationship between P-waves and QRS complexes, that succeed regularly,
being generated by a replacing pacemaker (atria and ventricles are dissociated =
transmission of the impulse from the atria to the ventricles is completely
blocked)
• Sometimes within the atria an arrhythmia can occur (Afib or AFlu)
• QRS morphology:
• A type: narrow complexes, more stable 40-60 bpm rhythm, the site of the block is
intranodal
• B type: wide complexes, unstable 20-40 bpm rhythm, risk of cardiac arrest, site of
the block is intrahissian of infrahissian
• EPS can precisely indicate the site of the block: V is preceded by H in the
suprahissian type and is dissociated by H in the infrahisian type.
QUESTION
DIAGNOSIS?
A. SSS
B. 1st degree AVB
C. Mobitz 2
D. Complete AVB
QUESTION
DIAGNOSIS?
A. SSS
B. 1st degree AVB
C. Mobitz 2
D. Complete AVB
SO – BOTH CAVB BUT…
IS THERE A DIFFERENCE?
A. Yes
B. No
ETIOLOGY
• Functional (reversible)
• Impairment of the autonomous NS
• Intoxication
• Dyselectrolytemia
• Organic
• Ischaemia-necrosis
• Inflamation
• Fibrosis
• Infiltrative diseases
• Degenerative diseases
TREATMENT PRINCIPLES AND METHODS
• Internal
• permanent
• endocardial
• epicardial
DIAGNOSIS
• Noninvasive
• IHR (Intrinsic Heart Rate)
• ECG ± ,,ladder’’ diagrams
• Holter monitoring / external LR / home telemetry
• Carotid sinus compression
• Tilt-test
• ECG exercise test
• Invasive
• Electrophysiologic study (EPS)
• Implantable monitoring devices (implantable loop recorder)
CARDIAC PACING
V V I R P
A A T
D D D
RVA VS. SEPTAL STIMULATION
PACEMAKERE
• Supraventricular
• WPW
• Atrial flutter
• Atrial fibrillation
• Ventricular
TACHYARRHYTHMIAS
• If hemodynamically unstable
• ECG:
• Short PR interval < 0.12 sec
• “ Delta” wave
• Wide QRS > 0.12 sec
• Negative T wave
• Pre-excited AFib
symptomatic
symptomatic
INTERMITENT “DELTA” WAVE
PERMANENT PRE-EXCITATION
AV RE-ENTRANT
TACHYCARDIA WITH
ANTIDROMIC
CONDUCTION
Regular
Regular tachyarrhythmia
tachyarrhythmia with
with wide
wide QRS
QRS
through”
through” presence
presence of
of the
the delta
delta wave
wave
fast
fast ventricular
ventricular response
response >
> 180-200/min
180-200/min
mechanism:
mechanism:
Antegrade
Antegrade conduction
conduction through
through the
the AP
AP
Retrograde
Retrograde conduction
conduction through
through the
the AVN
AVN
Differential
Differential diagnosis
diagnosis with
with sustained
sustained
monomorphic
monomorphic VT
VT
Increased
Increased risk
risk of
of sudden
sudden death
death ->
-> in
in case
case
of
of Afib
Afib ->
-> VFib
VFib
SVT IN WPW SDR. WITH ANTIDROMIC CONDUCTION
Regular
Regular tachyarrhythmia
tachyarrhythmia with
with wide
wide QRS;
QRS; no
no P-waves;
P-waves; dif.
dif. dg.
dg. with
with monomoprhic
monomoprhic V
WPW SDR. WITH AFIB
RISK OF DEATH EVALUATION IN WPW
SYNDROME
• Non-invasive :
• Intermitent pre-excitation = low risk(??)
• Dissapearance of pre-excitation upon procainamide administration
= low risk(?)
• Stress-testing (??)
• RR interval during AFib
• The shorter the RR interval, the higher the risk of death (<250 ms)
• Invasive = EPS:
• Determining the refractory period of the AP
TREATMENT OF WPW SD.
• Chronic, profilaxis:
• Class Ia, Ic, III antiarrhythmic drugs
• RF ablation of the AP/APs
• CONTRAINIDICATION:
• Digoxin
• Calcium blockers
VENTRICULAR
TACHYARRHYTHMIAS
• AV dissociation
• Independent atrial activation or retrograde VA conduction
• RISKS:
• Unstable hemodynamics
• Transition to VFib
VT MECHANISMS
• RE-ENTRY:
• PostMI
• ABNORMAL AUTOMATICITY:
• AMI: unparoxysmal VT (AIVR)
• RBBB SVT VT
• V1,2
rsR’ R(r’)
• Monophazic R
• qR
• RsR’ cu R>R’
• V6 qR rS
• rS
Wellens 1978
MORPHOLOGY
LEADS V1,2 SI V6
TSV TV
• LBBB type
• V1,2 > 0.03
• V6
• Q sau QS
Kindwall, 1988
wo RS in precordial leads
yes no
VT R – S > 100msec ?
yes No
VT A-V dissociation?
Yes
No
VT
VT morphology V1,2 and V6 ?
yes
No
VT
SVT with aberancy
TV POLIMORFA
POLYMORPHIC VT: TORSADE DU
POINTES
•• Fast
Fast VT,
VT, transition
transition to
to VFib
VFib
•• through
through EPD
EPD
•• with
with long
long QT
QT or
or normal
normal QT
QT
•• Causes:
Causes:
•• Long
Long QT
QT syndrome
syndrome
•• hipo
hipo K,
K, hipo
hipo Mg
Mg
•Type
•Type Ia
Ia and
and III
III AAD
AAD
•• Treatment:
Treatment:
•• IV
IV MgSO4
MgSO4
•• “Overdrive
“Overdrive pacing”
pacing”
•• Isuprel
Isuprel
•• Lidocaine,
Lidocaine, phenytoine
phenytoine
•• Long
Long QT:
QT: AICD,
AICD, bBlockers,
bBlockers,
flecainide,
flecainide, stelectomy.
stelectomy.
DG VT VS. SVT WITH WIDE QRS
• Wide QRS tachyarrhythmias:
• VT
• SVT with wide QRS
• SVT + pre-existent BBB
• SVT with aberrant conduction
• SVT + AVRT through antidromic mechanism (WPW)
• Amiodarone
• AA surgery
• ICD
VENTRICULAR
FIBRILLATION
• Fibrillation waves of different amplitude, in the absence of QRS complexes
• Mechanical asystole followed by electrical asystole
• Shock, cardiac arrest and death in 3-5 minutes from onset in the absence of CPR
• Causes:
• Acute ischaemia in AMI spontaneous severe ventricular arrhythmias
• Cardiomyopathy (OHCM !) AFib in WPW
• CHT with LVH COPD hypoxia
• Iatrogenic: drug, dyselectrolytemia, cardiac catheterization
• QT long syndrome with TdP asynchronous EES
• Preceded or not by VT:
• Treatment:
• EES 200-300 J CPR, OTI
• Bicarbonat EV daca CPR > 60 sec Lidocaina, bretiliu, amiodaron EV
• Corectarea cauzei
R.V. - Life threatening Brady & Tachy 2016
• Profilactic: DI sau amiodaron
TREATMENT OF MALIGNANT
VENTRICULAR ARRHYTHMIAS: ICD
• Indications:
• Secondary prophylaxis
• Any structural/electrical cardiomyopathy
with one event (resuscitated SCD, sustained
VT, VFib) in which no reversible cause is
observed
• Primary prophylaxis
• Technical advantages:
• IHD with LVEF < 35%
• Anti-tachy and anti-brady pacing
• Dil. CM with LVEF < 30-35% and NYHA ≥
III • Conversion-defibrillation with energy
• ARVC
• mortality compared to amiodarone in
• LQT Sd.
malignant symptomatic ventricular arrhythmias
• Brugada Sd.
• SQT Sd.
CLINICAL CASE
• 70 year-old man with diabetes collapses shortly after presenting to the
ER for palpitations
• HR 200 bpm, BP 60/40 mmHg
WHAT DO YOU DO?
• Bradyarrhythmias:
• Infra-nodal AV block
• Tachyarrhythmias:
• Malignant ventricular arrhythmias
Thank you!